Literature DB >> 11007090

Postoperative headache after surgery for vestibular schwannoma.

H Levo1, I Pyykkö, G Blomstedt.   

Abstract

Postoperative headache was studied among 251 patients who underwent operation for vestibular schwannoma. A questionnaire based on the McGill Pain Questionnaire and the Finnish Pain Questionnaire was sent to the patients. Twenty-one expressions describing postoperative headache were extracted with a factor analysis. The pain intensity was expressed on a visual analog scale, and the risk factors for postoperative headache were evaluated. Immediately after the operation, 154 subjects reported headache. Eighty-nine of the patients had had headache before operation, whereas 65 patients experienced headache only after operation. An average of 8.9 years after surgery, 93 patients still reported headache. Headache was a major problem for 27 subjects; 18 of the 27 had suffered from headache before operation. A retrosigmoidal approach, postoperative gait problems, preoperative headache, and small tumor size predicted postoperative problems with headache. When headache is present before operation, it tends to continue after operation, and if headache continues for 1 year, it usually persists without being reduced.

Entities:  

Mesh:

Year:  2000        PMID: 11007090     DOI: 10.1177/000348940010900913

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  13 in total

1.  Technical modifications of suboccipital craniectomy for prevention of postoperative headache.

Authors:  Damon A Silverman; Gordon B Hughes; Sam E Kinney; Joung H Lee
Journal:  Skull Base       Date:  2004-05

2.  Cross-cultural adaptation and validation of the NASS outcomes instrument in Spanish patients with low back pain.

Authors:  C Sarasqueta; O Gabaldon; I Iza; F Béland; P M Paz
Journal:  Eur Spine J       Date:  2005-02-17       Impact factor: 3.134

3.  Patient quality of life after vestibular schwannoma removal: possibilities and limits to measuring different domains of patients' wellbeing.

Authors:  Julia Kristin; Marcel Fabian Glaas; Jörg Schipper; Thomas Klenzner; Katrin Eysel-Gosepath; Philipp Jansen; Matthias Franz; Ralf Schäfer
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-06-08       Impact factor: 2.503

4.  Occipital Neuralgia following Acoustic Neuroma Resection.

Authors:  Loren N Riedy; Daniel M Heiferman; Caroline C Szujewski; Giselle Ek Malina; Elhaum G Rezaii; Brendan Martin; Kurt A Grahnke; Michael Doerrler; John P Leonetti; Douglas E Anderson
Journal:  J Neurol Surg B Skull Base       Date:  2021-02-22

5.  Dispersed Bone Spicules as a Cause of Postoperative Headache after Retrosigmoid Vestibular Schwannoma Surgery: A Myth?

Authors:  Yin Ren; Marin A McDonald; Paul Manning; Bridget V MacDonald; Marc S Schwartz; Rick A Friedman; Jeffrey P Harris
Journal:  J Neurol Surg B Skull Base       Date:  2021-12-31

6.  Postoperative headache after surgical treatment of cerebellopontine angle tumors: a systematic review.

Authors:  Louis Pogoda; Jelle S Nijdam; Diederik P J Smeeing; Eduard H J Voormolen; Fuat Ziylan; Hans G X M Thomeer
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-02-01       Impact factor: 2.503

7.  The treatment of chronic incisional pain and headache after retromastoid craniectomy.

Authors:  Thomas J Lovely
Journal:  Surg Neurol Int       Date:  2012-08-21

8.  Anesthesia dolorosa of trigeminal nerve, a rare complication of acoustic neuroma surgery.

Authors:  Foad Elahi; Kwo Wei David Ho
Journal:  Case Rep Neurol Med       Date:  2014-09-25

Review 9.  Pain following craniotomy: reassessment of the available options.

Authors:  Rudrashish Haldar; Ashutosh Kaushal; Devendra Gupta; Shashi Srivastava; Prabhat K Singh
Journal:  Biomed Res Int       Date:  2015-10-01       Impact factor: 3.411

10.  Postoperative Headache after Undergoing Acoustic Neuroma Surgery via the Retrosigmoid Approach.

Authors:  Noritaka Aihara; Hiroshi Yamada; Mariko Takahashi; Akira Inagaki; Shingo Murakami; Mitsuhito Mase
Journal:  Neurol Med Chir (Tokyo)       Date:  2017-10-12       Impact factor: 1.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.